Notice ID: a3e9245d890444ec95a29c805ddcb34dCombined Synopsis/Solicitation
Testing of compounds in CYP inhibition, hERG inhibition, PPB, and Caco-2 permeability assays
Archived on September 7, 2022. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 9:00 AM UTC−04:00
- Posted
- August 26, 2022
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 541380: Testing Laboratories and Services
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH NIDA
- Last updated
- Sep 9, 2025
Identifiers
- Solicitation number
- 75N95022Q00438
- Notice ID
- a3e9245d890444ec95a29c805ddcb34d
Description
Amendment 1: Uploading revised Statement of Work and Questions & Responses. Amendment 2: Uploading revised Statement of Work and Questions & Responses for Amendment 2. The National Center for Advancing Translational Sciences (NCATS), within the National Institutes of Health (NIH), requires the testing of compounds in CYP inhibition, hERG inhibition, PPB, and Caco-2 permeability assays. See attached Statement of Work for complete requirement details.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75N95022Q00438- Market Research
- Combined Synopsis
- Market ResearchJul 15, 2022
Testing of compounds in CYP inhibition, hERG inhibition, PPB, and Caco-2 permeability assays
- 3×Combined SynopsisCurrentAug 19, 2022
Testing of compounds in CYP inhibition, hERG inhibition, PPB, and Caco-2 permeability assays
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75N95022Q00438
Archive Date
Sep 7, 2022
Office Address
Bethesda, MD, 20892